Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation
on behalf the GRAALL group, Rathana Kim, Nicolas Boissel, Aurore Touzart, Thibaut Leguay, Florian Thonier, Xavier Thomas, Emmanuel Raffoux, Françoise Huguet, Patrick Villarèse, Cécile Fourrage, Loïc Passini, Mathilde Hunault, Stéphane Leprêtre, Patrice Chevallier, Thorsten Braun, Véronique Lhéritier, Sylvain Chantepie, Sébastien Maury, Martine Escoffre, Emmanuelle Tavernier, Yves Chalandon, Carlos Graux, Elizabeth Macintyre, Norbert Ifrah, Vahid Asnafi, Hervé Dombret, Ludovic Lhermitte
Topics & Concepts
Interleukin-7 receptorHematopoietic stem cell transplantationMedicineOncologyTransplantationStem cellInternal medicineNeuroblastoma RAS viral oncogene homologMinimal residual diseaseImmunologyLeukemiaT cellBiologyCancerKRASGeneticsIL-2 receptorColorectal cancerImmune systemAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and Treatment